← FDA Drug Approvals (Drugs@FDA)

LISDEXAMFETAMINE DIMESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS ELIZABETH · Approved 2023-08-25

Drug application

FDA Application #

ANDA202802

Application type

Abbreviated New Drug Application (Generic)

Brand name

LISDEXAMFETAMINE DIMESYLATE

Generic name

LISDEXAMFETAMINE DIMESYLATE

Active ingredients

LISDEXAMFETAMINE DIMESYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS ELIZABETH

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2023-08-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown